New therapeutic targets for infantile myofibromatosis

Genetic mutations may be targeted by currently available cancer therapies Two mutations central to the development of infantile myofibromatosis (IM)-a disorder characterized by multiple tumors involving the skin, bone, and soft tissue-may provide new therapeutic targets, according to… http://healthmedicinet.com/i/new-therapeutic-targets-for-infantile-myofibromatosis/